Wyss InstituteWomen’s Health – Wyss Institute

Help Advance Women’s Health Research

Jessica Leff — Mon, 06 Apr 2026 19:40:42 +0000

Endometriosis affects millions worldwide. Diagnosis can take 7 to 10 years and often relies on invasive surgery. The FemSmaht Research Team at the Wyss Institute is working to change that. We are conducting a study to develop a non-invasive method for detecting endometriosis and we are looking for menstruating individuals (endometriosis-positive and those without endometriosis) to help move this…

Source

Unravel: from tools for studying pathogen tolerance to hope for rare disease patients

Jessica Leff — Thu, 20 Nov 2025 17:49:56 +0000

Part of the Wyss Institute’s series on the positive, life-altering impact of federal research funding By Jessica Leff There are approximately 350 million people in the world with a rare disease, including 25-30 million Americans. About 80% of the disorders are genetic, and 95% of them have no FDA-approved treatments. Finding an effective drug is no small task; after an expensive and long…

Source

How federal funds fuel life-saving innovation

Jessica Leff — Thu, 20 Nov 2025 17:49:40 +0000

Source

Wyss Institute receives Wellcome Leap funding to develop first Human Organ Chip model for heavy menstrual bleeding

Jessica Leff — Fri, 19 Sep 2025 13:55:11 +0000

By Alexandra Jirstrand (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap’s $50 million The Missed Vital Sign program, which seeks to transform how menstruation is understood and treated in healthcare. The Wyss will use its pioneering Organ Chip technology to create the first human model of heavy menstrual…

Source

The Wyss Institute’s 2025-2026 Validation Projects

Jessica Leff — Thu, 14 Aug 2025 15:00:53 +0000

Throughout recent years, the Wyss’ Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick-starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are driven by multi-talented teams…

Source

ENDOx: Reimagining Endometriosis Care Through Precision Nanomedicine

admin — Tue, 29 Jul 2025 20:12:37 +0000

Endometriosis is characterized by the abnormal growth of tissue resembling the endometrium outside the uterus. It is estimated to affect 10–15% of reproductive-aged women and is associated with significant morbidity, including chronic pelvic pain and infertility. With no curative treatments currently available, standard therapies rely on hormonal suppression or invasive surgery, both of which are…

Source

The Tipping Point for Women’s Health

Mariel Schoen — Mon, 23 Jun 2025 14:00:29 +0000

Last month, the Wyss Institute had the honor of hosting the Women’s Health Access Matters (WHAM) Spring Forum, convening researchers, industry leaders, investors, and advocates committed to closing the gender health gap. The event brought together cross-sector voices to explore bold ideas, share scientific breakthroughs, and catalyze action across women’s brain, heart, and reproductive health.

Source

Sandy Elmehrath on Closing the Gender Health Gap by Driving Progress in Endometriosis Management and Care

Jessica Leff — Tue, 25 Mar 2025 14:54:32 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Sandy Elmehrath is all too familiar with the consequences of the gender health gap. Her great-aunt endured many years of pain from stomach cancer, only to be diagnosed after it was too late…

Source

Let’s talk about women’s health

Jessica Leff — Fri, 07 Mar 2025 13:00:42 +0000

When promoting the ReConstruct technology, which improves the lives of patients undergoing breast reconstruction, our social media team found that the use of the word “breast” was deemed as “inappropriate” by the algorithms of certain social media sites. Thus, these posts performed more poorly than similar posts. Without the ability to talk openly about Women’s Health, it will be virtually…

Source

ARPA-H-recognized iNode team seeks vital support to treat ovarian cancer with first-in-class implantable immune organs

Mariel Schoen — Thu, 30 Jan 2025 20:13:20 +0000

(BOSTON) — Ovarian cancer is deadlier than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women’s health, a team at the Wyss Institute at Harvard University has developed “iNodes…

Source